NUVECTIS PHARMA INC (NVCT) — insider trading
Health Care · NASDAQ
NUVECTIS PHARMA INC (NVCT) has 13 reported SEC Form 4 insider transactions in our data, including 4 open-market purchases among the most recent 13 (latest 2026-08-03).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-03 | Carson Michael J. | Officer (Vice President, Finance) | Grant / award / vesting | 30,000 | — | $0 | Form 4 |
| 2026-06-30 | BENTSUR RON | Director, Officer (Chairman & CEO), 10% owner | Open-market purchase | 12,500 | $20.00 | $250.0K | Form 4 |
| 2026-06-30 | Mosseri Marlio Charles | 10% owner | Open-market purchase | 50,000 | $18.32 | $916.0K | Form 4 |
| 2026-06-11 | Kaplan Matthew L. | Director | Grant / award / vesting | 35,000 | — | $0 | Form 4 |
| 2026-06-11 | Sanchez Juan | Director | Grant / award / vesting | 35,000 | — | $0 | Form 4 |
| 2026-06-11 | Oliviero James F III | Director | Grant / award / vesting | 35,000 | — | $0 | Form 4 |
| 2026-06-11 | Hoberman Kenneth | Director | Grant / award / vesting | 35,000 | — | $0 | Form 4 |
| 2026-01-06 | Carson Michael J. | Officer (Vice President, Finance) | Grant / award / vesting | 61,200 | — | $0 | Form 4 |
| 2026-01-06 | Poradosu Enrique | Officer (Chief Science & Business Off) | Grant / award / vesting | 150,000 | — | $0 | Form 4 |
| 2026-01-06 | BENTSUR RON | Director, Officer (Chairman & CEO), 10% owner | Grant / award / vesting | 150,000 | — | $0 | Form 4 |
| 2026-01-06 | Shemesh Shay | Officer (Chief Dev. & Ops. Officer) | Grant / award / vesting | 150,000 | — | $0 | Form 4 |
| 2025-11-05 | Sanchez Juan | Director | Open-market purchase | 13,000 | $5.79 | $75.3K | Form 4 |
| 2025-11-05 | BENTSUR RON | Director, Officer (Chairman & CEO), 10% owner | Open-market purchase | 5,000 | $5.72 | $28.6K | Form 4 |
Ask the chat about NVCT's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: NUVECTIS PHARMA INC (NVCT).
Last updated 2026-08-03 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.